Vigorous response of cytotoxic T lymphocytes associated with systemic activation of CD8+ T lymphocytes in fulminant hepatitis B

Liver International

Volumn 24, Issue 6, 2004, Pages 561-567

  Kondo, Y ^a   Kobayashi, Koju ^b   Asabe, S ^c   Shiina, M ^d   Niitsuma, H ^a   Ueno, Y ^a   Kobayashi, T ^e   Shimosegawa, T ^a  

^a TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b TOHOKU UNIVERSITY   (Japan)

^c JICHI MEDICAL UNIVERSITY   (Japan)

^d SENDAI CITY MEDICAL CENTER   (Japan)

^e Furukawa City Hospital   (Japan)

Author keywords

CTL; Hepatitis B virus; HLA DR

Indexed keywords

ALANINE AMINOTRANSFERASE; CD45 ANTIGEN; CD8 ANTIGEN; GAMMA INTERFERON; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B(E) ANTIGEN; HLA DR ANTIGEN; PERFORIN;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANTIGEN EXPRESSION; ARTICLE; BLOOD SAMPLING; CELL DIFFERENTIATION; CELL ISOLATION; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; DISEASE EXACERBATION; FLOW CYTOMETRY; HEPATITIS B; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIVER TRANSPLANTATION; LYMPHOCYTE SUBPOPULATION; MALE; PHENOTYPE; T LYMPHOCYTE ACTIVATION;

ADULT; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CD8-POSITIVE T-LYMPHOCYTES; DISEASE PROGRESSION; FEMALE; HEPATECTOMY; HEPATIC ENCEPHALOPATHY; HEPATITIS B; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHOCYTE ACTIVATION; MALE; MIDDLE AGED; SAMPLING STUDIES; SENSITIVITY AND SPECIFICITY; T-LYMPHOCYTES, CYTOTOXIC;

EID: 11144317786     PISSN: 14783223     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1478-3231.2004.0982.x     Document Type: Article

References (22)

1. Kimura K, Ando K, Tomita E, et al. Elevated intracellular IFN-gamma levels in circulating CD8+ lymphocytes in patients with fulminant hepatitis. J Hepatol 1999; 31: 579-83.
2. Tiollais P, Pourcel C, Dejean A. The hepatitis B virus. Nature 1985; 317: 489-95.
3. Kagi D, Ledermann B, Burki K, et al. Molecular mechanisms of lymphocyte-mediated cytotoxicity and their role in immunological protection and pathogenesis in vivo. Annu Rev Immunol 1996; 14: 207-32.
4. Penna A, Chisari F V, Bertoletti A, et al. Cytotoxic T lymphocytes recognize an HLA-A2-restricted epitope within the hepatitis B virus nucleocapsid antigen. J Exp Med 1991; 174: 1565-70.
5. Rehermann B, Fowler P, Sidney J, et al. The cytotoxic T lymphocyte response to multiple hepatitis B virus polymerase epitopes during and after acute viral hepatitis. J Exp Med 1995; 181: 1047-58.
6. Ando K, Moriyama T, Guidotti L G, et al. Mechanisms of class I restricted immunopathology. A transgenic mouse model of fulminant hepatitis. J Exp Med 1993; 178: 1541-54.
7. Ando K, Guidotti L G, Wirth S, et al. Class I-restricted cytotoxic T lymphocytes are directly cytopathic for their target cells in vivo. J Immunol 1994; 152: 3245-53.
8. Kondo Y, Asabe S, Kobayashi K, et al. Recovery of functional cytotoxic T lymphocytes during lamivudine therapy by acquiring multi-specificty. J Med Virol (in press).
9. Urbani S, Boni C, Missale G, et al. Virus-specific CD8+ lymphocytes share the same effector-memory phenotype but exhibit functional differences in acute hepatitis B and C. J Virol 2002; 76: 12423-34.
10. Trey C, Davidson C S. The management of fulminant hepatic failure. Prog Liver Dis 1970; 3: 282-98.
11. Shimizu T, Tokushige K, Yamaguchi N, et al. Discrimination of two different clinical entities, acute-type and subacute-type, human fulminant hepatitis by peripheral blood lymphocyte subsets. J Gastroenterol Hepatol 1999; 14: 274-80.
12. Altman J D, Moss P A, Goulder P J, et al. Phenotypic analysis of antigen-specific T lymphocytes. Science 1996; 274: 94-6.
13. Tough D F, Borrow P, Sprent J. Induction of bystander T cell proliferation by viruses and type I interferon in vivo. Science 1996; 272: 1947-50.
14. Hoshino Y, Morishima T, Kimura H, et al. Antigen-driven expansion and contraction of CD8+-activated T cells in primary EBV infection. J Immunol 1999; 163: 5735-40.
15. Sallusto F, Lenig D, Foster R, et al. Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature 1999; 401: 708-12.
16. Champagne P, Ogg G S, King A S, et al. Skewed maturation of memory HIV-specific CD8 T lymphocytes. Nature 2001; 410: 106-11.
17. Francavilla V, Accapezzato D, De Salvo M, et al. Subversion of effector CD8+ T cell differentiation in acute hepatitis C virus infection: exploring the immunological mechanisms. Eur J Immunol 2004; 34: 427-37.
18. Kimura K, Kakimi K, Wieland S, et al. Interleukin-18 inhibits hepatitis B virus replication in the livers of transgenic mice. J Virol 2002; 76: 10702-7.
19. Tsutsui H, Adachi K, Seki E, Nakanishi K. Cytokine-induced inflammatory liver injuries. Curr Mol Med 2003; 3: 545-59.
20. Tokushige K, Hasegawa K, Yamauchi K, Hayashi N. Analysis of natural killer cells and interleukin-15 in patients with acute and fulminant hepatitis. Hepatology Res 2002; 23: 31-7.
21. Lamontagne L, Lusignan S, Page C. Recovery from mouse hepatitis virus infection depends on recruitment of CD8(+) cells rather than activation of intrahepatic CD4(+)alphabeta(-)TCR(inter) or NK-T cells. Clin Immunol 2001; 101: 345-56.
22. Matsuoka S, Tsurui H, Abe M, et al. A monoclonal antibody to the alpha2 domain of murine major histocompatibility complex class I that specifically kills activated lymphocytes and blocks liver damage in the concanavalin A hepatitis model. J Exp Med 2003; 198: 497-503.